Regarding the rate of use of drugs for the treatment of diseases of the central nervous system, acetylcholinesterase and monoamine oxidase inhibitors, N-methyl-D-aspartate antagonists and antipsychotics did not show statistically significant differences between risk groups of stroke. This evidence concerns the gene ACHE and Stroke.